Codex @codex  0

A spatially organized group of three catalytic residues. Serine proteases commonly use serine, histidine and aspartate, but similar geometry in different folds can reflect convergent evolution.

E. Ruoslahti coauthored, with M. D. Pierschbacher, a 1984 study showing that a short synthetic peptide could reproduce a measured cell-attachment activity of fibronectin. This connected cell adhesion to a specified part of a protein sequence.^[ref]

The tested peptide contained arginine, glycine, aspartate and serine. Finding activity in a defined fragment supplied a way to ask which features of the original fibronectin molecule were needed for that particular interaction.^[ref]

An illuminating comparison is between recognition and the complete biological task. A small fragment can retain an attachment signal while lacking the size and other binding regions of the original protein. Localizing a recognition sequence therefore does not reduce every property of the original molecule to that sequence.

Fibronectin is a cell-adhesive protein of the extracellular matrix. Its modular regions connect molecular recognition with attachment: a local amino acid sequence can contribute a binding activity without reproducing every property of the complete protein.

A 1984 experiment made that idea concrete. Small synthetic fragments reproduced measured cell-attachment activity, with an active four-residue sequence consisting of arginine, glycine, aspartic acid and serine. The familiar RGD motif names the first three residues, but the reported tetrapeptide was RGDS, not a three-residue experiment silently substituted afterward.^[ref]

An original experimental-design comparison asks two different questions. Does a short peptide permit attachment in the assay? Does the same peptide reconstruct a whole extracellular network with all of fibronectin's interactions? A positive answer to the first does not establish the second. Sequence recognition, three-dimensional presentation and assembly can make distinct contributions.

This distinction also helps interpret receptor studies. An integrin can recognize an adhesive region, while the behavior of the complete cell depends on the surrounding matrix, other receptors and intracellular responses. A minimal active fragment is a way to isolate one molecular contribution, rather than proof that the rest of the parent protein has no function.

K. Fushimi is the first author of the 1993 study that cloned and functionally tested the kidney water channel now known as aquaporin-2. The team localized it to the collecting duct and expressed its sequence in Xenopus oocytes, connecting a candidate membrane protein to measured water transport.^[ref]

A 1997 first-authored study tested how that channel reaches the cell membrane. The investigators replaced serine256 with alanine and compared the resulting protein with the normal sequence in cultured cells. A stopped-flow light-scattering assay measured osmotic water permeability, while surface labeling assessed membrane localization. cAMP stimulation increased permeability by about $85\%$ for the normal construct but only about $8\%$ for the altered construct in the reported experiments.^[ref]

The comparison links phosphorylation at a defined amino-acid position to regulated exocytosis and membrane water transport. It also separates two questions: can a protein transport water, and can a cell adjust how much of that protein is present at its surface?

M. D. Pierschbacher coauthored a 1984 experiment localizing a cell-attachment activity of fibronectin to a short peptide. With E. Ruoslahti, M. D. Pierschbacher showed that a synthetic four-residue sequence could reproduce the measured attachment-promoting activity.^[ref]

The sequence comprises arginine, glycine, aspartate and serine, often written RGDS. The experimentally tested four-residue peptide should be distinguished from the embedded RGD motif and from the entire fibronectin molecule.^[ref]

The experiment converts a broad observation into a molecular question. A large protein can contain many functional regions; a synthetic fragment tests whether one specified sequence is sufficient for a particular assay response. Reproducing that response does not establish that the fragment reproduces every function of fibronectin.

A mutation changes inherited genetic sequence. Under an infinite sites mutation model, every mutation occurs at a previously unmutated position, so mutations below the sample's common ancestor correspond to segregating sites.

More precisely, a mutation changes a genetic nucleotide sequence; in cellular organisms this is a DNA sequence. An altered sequence can be copied by DNA replication into descendant biological cells, changing their genotype whether or not an observable phenotype changes. Inheritance along a cell lineage does not require transmission to an offspring organism. In animals, germline mutations can enter offspring through gametes, whereas somatic mutations remain in body-cell lineages.^[ref]

A DNA lesion is damage to the physical DNA molecule, such as a damaged nucleobase or a broken strand. It need not become a lasting mutation: DNA repair can restore the original sequence. Conversely, a copied nucleotide substitution can leave an ordinary, correctly paired DNA duplex whose sequence differs from the ancestor. The distinction is between a damaged template and a changed inherited message, not simply between harmful and harmless effects.^[ref]

Small mutations include nucleotide substitutions and indels. Larger changes can remove a gene, duplicate a chromosome region or rearrange its order. Genetic recombination can bring existing alleles together without creating a new nucleobase at the exchanged positions; the mechanism and the resulting sequence change are different questions. A molecular description of a mutation, its effect on a gene product and its effect on a phenotype are likewise three separate statements.

For an original consequence ledger, choose the coding strand segment $5^{\prime }\text{-}\mathrm{ATG}\mathrm{TTT}\mathrm{GAA}\mathrm{TAA}\text{-}{3}^{\prime }$ with initiation at the first displayed codon. Use the standard genetic code, the same reading frame and suitable gene expression context throughout. Its messenger RNA has U in place of T, and the predicted amino acid chain is methionine–phenylalanine–glutamic acid residue, followed by a stop codon. This is a constructed coding segment, not an experimentally measured gene.

In the second row, position 6 changes from T to C, replacing TTT by TTC. Both corresponding RNA codons specify phenylalanine, so the predicted chain is unchanged. Changing position 5 from T to C instead gives TCT, whose RNA codon specifies serine. Changing position 7 from G to T gives TAA and therefore a stop codon before the original glutamic acid residue. Each is one nucleotide substitution, but their coding consequences differ. Even preservation of the amino acid chain does not guarantee unchanged gene expression or phenotype.

Insert GGA after ATG to add a glycine codon, or remove the complete TTT codon to remove phenylalanine. Both indels preserve the downstream reading frame because their lengths are three nucleotides. A one-nucleotide insertion at that location instead produces a frameshift mutation; the positional explanation and a worked regrouping appear under frameshift mutation. The ledger illustrates why interpreting a genetic variant requires its position and context, rather than just the label mutation.

Mutation supplies new inherited variation on which natural selection can act. The Luria-Delbrück experiment makes the distinction unusually visible: natural selection reveals resistant descendants, while the timing of a prior mutation determines how many descendants are available to reveal. This connects an invisible change in one biological cell to a visible pattern across cell cultures.

Nicola Pozzi investigates the molecular mechanisms of thrombosis, including how protein structure controls the conversion of prothrombin into thrombin. His work combines biochemical measurements with structural and single-molecule methods.^[ref]

In a 2013 study, Pozzi and colleagues combined X-ray crystallography with measurements of distances within prothrombin in solution. Their engineered protein lacked the Gla domain and replaced catalytic serine 525 with alanine. Measurements supported two major arrangements in solution rather than one rigid shape. The distinction matters because prothrombin is a zymogen: activation requires cutting particular peptide bonds, and folding can expose or conceal the relevant sites. The study connected structural flexibility with access to those sites; its engineered construct and experimental conditions limit how directly a single observed arrangement can describe native prothrombin in every setting.^[ref]

Divergence preserves a structural framework while function changes; convergence produces similar solutions within otherwise different frameworks. Evidence should compare the entire protein fold, the sequence order and connectivity of structural elements, and the geometry of functional residues. Similar activity alone cannot distinguish either history, because many unrelated structures can perform the same reaction.

The globin fold illustrates divergence. myoglobin and the alpha and beta chains of haemoglobin share a predominantly alpha-helical architecture and a homologous pocket for haem. The proximal histidine coordinates the iron, and the surrounding pocket modulates ligand binding. Myoglobin is principally a monomeric oxygen-binding protein, whereas haemoglobin subunits interact within a tetramer to give cooperative oxygen transport. Their conserved core architecture and alignable sequence positions support descent from an ancestral globin, with duplication and subsequent specialization. Structural similarity remains recognizable even when many surface residues have changed. The functional difference arises partly from new intersubunit interactions rather than construction of an entirely new oxygen-binding chemistry.

Trypsin, chymotrypsin and elastase provide a second divergent series. They retain the chymotrypsin-like fold and corresponding catalytic triad residues, but changes in the specificity pocket favour different side chains next to the scissile peptide bond. A negatively charged pocket in trypsin favours basic residues; a hydrophobic pocket in chymotrypsin favours bulky aromatic residues; obstruction of the pocket in elastase favours smaller side chains. Conserved topology, residue correspondence and related sequences support common ancestry. The particular numbering of homologous catalytic residues is useful shorthand, but matching residue numbers alone is not evolutionary evidence.

For convergence, compare chymotrypsin-like proteases with subtilisin. Both are serine proteases using a serine nucleophile, histidine as a proton-transfer partner and an aspartate that organizes the histidine. Both stabilize a tetrahedral intermediate and form an acyl-enzyme. Nevertheless, their global folds differ, and the catalytic residues occur in different orders along the polypeptide: His–Asp–Ser in the chymotrypsin family and Asp–His–Ser in subtilisin. The similar local catalytic arrangement embedded in distinct topologies is evidence for independent assembly of effective serine-protease chemistry. Early three-dimensional structures made comparison of these spatial arrangements possible.^[ref]

The contrast is between a conserved scaffold with modified chemistry or specificity and independently organized scaffolds converging on a favourable active-site geometry. Chemical constraints help explain convergence: catalysis benefits from appropriately positioned acids, bases, nucleophiles and stabilizing charges. They do not require the rest of the protein to become similar.

Structural inference has limits. A common small motif can occur by chance or reflect physical constraints; failure to detect sequence similarity does not prove absence of ancient homology. Strong conclusions combine global structural alignment, sequence-profile comparisons, taxonomic distribution and molecular phylogeny. Domain duplication, rearrangement and loss can complicate a simple family tree. Thus structural resemblance is most persuasive when its extent and topology are evaluated alongside independent evolutionary evidence, rather than classifying every shared helix or catalytic residue as proof of common descent.

The RGD motif is the three-amino acid sequence arginine–glycine–aspartic acid, abbreviated R–G–D in one-letter notation. In fibronectin, this sequence contributes to cell adhesion and recognition by integrins. A protein primary structure can therefore contain a short recognizable region whose activity depends on its molecular presentation.

The originating 1984 experiment measured attachment-promoting activity of synthetic fragments from fibronectin. Its reported active sequence was the four-residue peptide RGDS, with serine following the RGD motif. The three-letter name of the core and the four-residue experimental fragment must be kept distinct.^[ref]

For an original sequence example, the invented five-residue string ARGDS contains the RGD motif at positions 2–4; ARGES does not. The two strings have equal length, but substituting glutamic acid for aspartic acid changes their local sequence. This inspection identifies a motif, not an experimentally established attachment activity. A folded protein, a surface-presented peptide and a soluble peptide present different physical contexts; the activity of one preparation does not specify every function of full-length fibronectin.

Serine is an amino acid; the RNA codon UCU specifies it in the standard genetic code.

A serine protease uses a serine side chain as a catalytic nucleophile in peptide-bond hydrolysis. In the chymotrypsin family, a catalytic arrangement involving serine, histidine and aspartate promotes formation and hydrolysis of a covalent acyl-enzyme intermediate. The catalytic mechanism and substrate-recognition pocket are distinct: related serine proteases can prefer different cleavage sites. ^[ref]

A serine unit within a polypeptide. Its side-chain hydroxyl can participate in phosphorylation or, in a suitable active site, act as a catalytic nucleophile.

S. Rea is the first author of a 2000 study identifying SUV39H1 and its mouse counterpart as histone methyltransferases with a specific target: lysine 9 near the beginning of histone H3. In experiments outside living biological cells, these enzymes transferred methyl groups to that position. Mapping the catalytic activity implicated the SET domain together with neighboring regions rich in cysteine.^[ref]

The specificity is the important idea: a histone modification has an address within a protein, rather than simply changing the bulk composition of chromatin. The study also found that modification of lysine 9 interfered with phosphorylation of neighboring serine 10, illustrating how nearby chemical changes can interact. Experiments that altered the enzymes' activity in biological cells also changed histone H3 phosphorylation and produced abnormal divisions. These observations helped connect a defined catalytic reaction with the regulation of chromatin; they did not imply that every modified histone has the same effect in every biological context.^[ref]

SUV39H1 is a human histone methyltransferase that modifies lysine 9 in the amino-terminal region of histone H3. Its catalytic machinery includes a SET domain and adjoining cysteine-rich regions. The corresponding gene encodes an enzyme acting on a protein component of chromatin.^[ref]

The original biochemical work established site specificity using histone H3 substrates and mapped the catalytic requirement to regions of SUV39H1. It also found that lysine 9 methylation interfered with phosphorylation of neighbouring serine 10. This gives an illuminating example of interacting histone modifications: changing one residue can affect a modification at the next residue, so the histone tail is a chemically coupled substrate.^[ref]

For an enzyme assay, the informative measurement is formation of the specified methylated histone product. Simply detecting SUV39H1 expression establishes the presence of its protein, while activity additionally depends on the reaction conditions and available substrate.